Stocks · Health care · Pharmaceutical Preparations

Dyne Therapeutics, Inc.

DYN Clue Score43
United States Fiscal year ends December CIK 0001818794 Results filed 5 Nov 2026

What the insiders did Mostly scheduled

Insider
Date
Role
Action
Shares
Price
Amount
Brian S Posner
2 Oct 2026
Director
Buy
2,500
$16.00
$40.00K
Brian S Posner
8 Jun 2026
Director
Buy
2,000
$16.94
$33.88K
Brian S Posner
3 Jun 2026
Director
Buy
2,500
$17.48
$43.70K
Brian S Posner
26 May 2026
Director
Buy
2,000
$18.21
$36.42K
Brian S Posner
20 May 2026
Director
Buy
2,500
$17.12
$42.80K
Brian S Posner
30 Mar 2026
Director
Buy
2,000
$17.08
$34.16K
Brian S Posner
11 Mar 2026
Director
Buy
2,000
$19.35
$38.70K
Brian S Posner
6 Mar 2026
Director
Buy
3,000
$15.06
$45.18K

What was left out

Form 4 filings counted 60
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 121
Sales straight out of an exercise 0
Sales at will 1
Transactions with no price 0
Shares from compensation/vesting 451,625
History held since 18 Sep 2020